메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Naoki Minami (Department of Gastroenterology and Hepatology Graduate School of Medicine Kyoto University) Minoru Matsuura (Department of Gastroenterology and Hepatology Graduate School of Medicine Kyoto University) Yorimitsu Koshikawa (Department of Gastroenterology and Hepatology Graduate School of Medicine Kyoto University) Satoshi Yamada (Department of Gastroenterology and Hepatology Graduate School of Medicine Kyoto University) Yusuke Honzawa (Department of Gastroenterology and Hepatology Graduate School of Medicine Kyoto University) Shuji Yamamoto (Department of Gastroenterology and Hepatology Graduate School of Medicine Kyoto University) Hiroshi Nakase (Department of Gastroenterology and Hepatology Sapporo Medical University School of Medicine)
저널정보
대한장연구학회 Intestinal research Intestinal research Vol.15 No.1
발행연도
2017.1
수록면
90 - 96 (7page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background/Aims: Our physicians work to expand the possibilities to treat female patients with inflammatory bowel disease(IBD) who wish to become pregnant. Although many drugs, including 5-aminosalicylate (5-ASA), corticosteroids, immunomodulators,and biologics, are used safely during pregnancy, few reports have described the therapeutic regimen throughoutpregnancy and the management of patients who relapse during pregnancy precisely. The aim of this study was to assess themanagement of patients with IBD during pregnancy. Methods: We identified 19 patients (five with Crohn’s disease and 14with ulcerative colitis [UC]) who became pregnant with a total of 23 pregnancies between May 2005 and May 2015 by reviewingthe medical records of Kyoto University Hospital. The following data were collected: the maternal variables, the IBD treatmenttype, the disease activity, the pregnancy outcome, and the mode of delivery. Results: Among the 19 patients, 18 had becomepregnant after being diagnosed with IBD, while one had developed UC newly after pregnancy. Throughout the gestation,all patients were treated with probiotics, 5-ASA, prednisolone, cytapheresis, or infliximab. The relapse rate during pregnancywas 21.7% (5/23 cases). The five patients who experienced a relapse were able to pursue their pregnancy after intensification oftheir treatments. There were no adverse fetal or neonatal problems, except in one case that required an emergency Caesareansection because of placental dysfunction and in which a very low-birth-weight infant was born preterm. Conclusions: Ourpresent data confirmed that even if the disease flares up during pregnancy, good pregnancy outcomes can be achieved with anoptimal intensification of the patient’s treatment.

목차

등록된 정보가 없습니다.

참고문헌 (21)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0